The central challenge the team confronted is one that has long frustrated microbiome researchers. When an antibiotic treatment changes both the composition of the gut microbiota and the expression of host genes, it is extraordinarily difficult to determine which host changes are caused by the microbial shifts and which are caused by the drug acting directly on host cells. Germ-free animals can reveal whether a perturbation acts directly on the host, but until now there was no rigorous statistical tool that could predict, from observational data in conventional animals, whether a given host response was microbiota dependent or microbiota independent. The researchers set out to close that gap.

Their experimental design was ambitious. They treated specific pathogen-free mice with four commonly used antibiotics—vancomycin, ampicillin, metronidazole and neomycin—either individually or in combination, and delivered them through three different routes: oral gavage, intraperitoneal injection and intravenous injection. Mice were treated twice daily for three and a half days, mimicking the shorter antibiotic regimens now favoured in clinical practice. Stool samples were collected before and after treatment to profile the microbiota using 16S rRNA amplicon sequencing, while colonic tissue was harvested for RNA sequencing to capture the host transcriptional response.

One of the most surprising findings concerned vancomycin itself. This is a large, hydrophilic molecule that should cross the gut mucosa poorly, which is precisely why it is given orally to treat intestinal infections like Clostridioides difficile. Yet when the researchers administered vancomycin systemically by intraperitoneal injection, mass spectrometry confirmed that detectable amounts of the drug reached the small intestinal and colonic lumen. The consequences for the microbiota were distinct depending on the route: oral administration drove a dramatic increase in Enterobacteriaceae, while systemic treatment increased Tannerellaceae. Both are Gram-negative families, but the fact that systemic vancomycin reshapes the gut community at all overturns a long-standing assumption about the drug’s pharmacokinetics.

When the team turned to the host transcriptome, the picture became even more interesting. Intraperitoneal vancomycin affected the largest number of colonic transcripts of any antibiotic studied, and gene set enrichment analysis revealed that the affected pathways included antigen presentation via major histocompatibility complex class II molecules—a core immune function of the gut epithelium. A random forest classifier trained on the transcriptional data could distinguish each antibiotic and each administration route with high accuracy, confirming that different antibiotics produce unique host transcriptional signatures. Remarkably, when the four antibiotics were combined, many of the individual effects on core clock genes were suppressed, and even clinically relevant pairs such as vancomycin plus metronidazole produced non-additive effects on the host that could not be predicted from the single-drug responses.

To disentangle microbiota-dependent from microbiota-independent effects, the researchers developed CompoRes, a computational tool that integrates microbial compositional data with host gene expression profiles. The algorithm first infers correlations among microbial taxa using SPARCC, a method designed for compositional data, and hierarchically clusters them into operational compositional units. It then computes log-ratios of all possible pairs of these units and correlates them with gene expression. Because the number of comparisons is vast relative to sample size, the tool generates a null distribution by shuffling the data at least fifty times, yielding a rigorous P value for each gene. The approach was validated on synthetic data and on experimental ground truths: germ-free mice treated with intraperitoneal vancomycin, where the drug can only act directly on the host, and germ-free mice receiving a faecal microbiota transplant from orally treated mice, where the effect can only flow through the microbiota.

Applying CompoRes to the clock genes Ciart, Nfil3, Per3 and Dbp revealed a striking route-dependent dichotomy. In mice treated orally with vancomycin, the expression of these core circadian regulators correlated strongly with changes in microbiota composition, consistent with previous work showing that the gut microbiota oscillates in a circadian pattern and programs host transcriptome oscillations. But in mice receiving the same drug systemically, the same genes showed no correlation with the microbiota whatsoever. The tool had predicted, purely from data in conventional animals, that systemic vancomycin disrupts circadian gene expression in the gut through a direct, non-microbial pathway. Subsequent experiments in germ-free mice confirmed this prediction: intraperitoneal vancomycin altered core clock gene expression across a 24-hour cycle in animals that had no microbes at all.

The physiological consequences of this microbiota-independent disruption proved to be behavioural. In germ-free mice, vancomycin reversed the normal diurnal expression pattern of metabolic genes such as Ppara, Cd36, Lpl and Fabp4, which typically peak during the light phase when nocturnal mice are fasting. The team found that vancomycin reduced food intake in both germ-free and conventional mice, with feeding normalising after treatment ceased. Transcriptional analysis showed that the drug uniquely altered enteric nervous system transcripts, and immunofluorescence imaging revealed that fluorescein-labelled vancomycin was internalised into myenteric plexus neurons following systemic injection but not oral administration. The drug induced expression of the neuropeptide neuromedin U and its receptor NMUR2, and mice lacking neuromedin U were resistant to vancomycin-induced hypophagia, pinpointing the molecular mechanism by which the antibiotic suppresses appetite.

The downstream immune consequences were equally profound. Expression of the MHC class II genes H2-Aa and H2-Ab1 in the colonic epithelium normally peaks at a specific circadian time point, and the researchers discovered that this oscillation persists in germ-free mice—unlike in the small intestine, where microbial presence is required. They further showed that glucose directly induces H2-Ab1 expression in fasting germ-free mice and in intestinal epithelial cells in vitro, indicating that colonic MHC class II expression follows a diurnal, glucose-responsive pattern dictated by feeding. Vancomycin-induced hypophagia suppressed this peak entirely, meaning the antibiotic disrupts a key antigen-presentation rhythm in the gut through a direct behavioural pathway rather than through any change to the microbiota.

Perhaps most remarkably, the molecular response to vancomycin proved to be evolutionarily conserved. When the researchers reared Drosophila melanogaster on vancomycin-laced food and sequenced adult fly brain RNA, they found that the fly homologues of the mammalian Clock gene and its downstream target timeless were altered, as was klumpfuss, a gene controlling feeding behaviour in flies. The fly orthologue of the NMU receptor was induced in response to the drug, mirroring what the team had observed in mice. This preservation of the vancomycin response across evolutionarily distant organisms suggests that the antibiotic taps into an ancient cellular stress pathway, one that links metabolism, circadian biology and immunity through mechanisms that operate independently of any microbe. The work challenges the microbiota-only model of antibiotic action and provides a framework for identifying direct effects of environmental perturbations on host physiology, with implications for understanding how antibiotics shape immunity, metabolism and circadian health in clinical practice and beyond.

Subject of Research: Microbiology

Article Title: Disentangling microbiota-dependent and -independent impacts of antibiotics on host physiology

Article References: Zelik, L., Levin, Y., Sawaed, J., Telpaz, S., Zigdon, M., Nuriel-Ohayon, M., Rubin, E., Gordon, A., Mogilevski, Z., Yehuda, A., Awad, A., Shaalan, H., Ben-Simon, S., Modilevsky, S., Naama, M., Dalvi, J., Moadi, L., Kurtz, M., Perez, S., … Bel, S. (2026). Disentangling microbiota-dependent and -independent impacts of antibiotics on host physiology. Nature Microbiology. https://doi.org/10.1038/s41564-026-02453-w

Image Credits: AI Generated

DOI: 10.1038/s41564-026-02453-w

Keywords: antibiotics, gut microbiota, circadian rhythms, vancomycin, MHC class II, neuromedin U, germ-free mice, CompoRes, host physiology, microbiome, Disentangling, microbiota-dependent

The new study, published in the journal iScience, drew on an unusual treasure trove of data: minute-level recordings from personal Fitbit devices worn by participants in the National Institutes of Health’s All of Us Research Program, linked to their electronic health records. The researchers, led by Ruby Kim along with Julia Evanski, Tristin Smith, circadian biologist Daniel Forger, pain specialist Chelsea Kaplan, chronic pain researcher Daniel Clauw, and rehabilitation scientist Daniel Whibley, asked a deceptively simple question. Do sleep patterns and circadian rhythms, the internal biological cycles that govern everything from heart rate to hormone release, change in the days and weeks leading up to the moment a clinician documents persistent pain following a procedure?

To answer it, the team identified 116 clinical records of persistent pain following a procedure across 98 participants, each dated at least 90 days after a surgical operation, the conventional threshold at which pain is considered persistent rather than part of normal healing. The procedures involved ranged from hysterectomies to hip and knee replacements to thoracic aortic replacement. For each record, the researchers examined the 30 days of wearable data preceding it, extracting two families of measurements. The first came from Fitbit’s sleep tracking: bedtime, waketime, and total sleep duration. The second was more novel, derived from a mathematical model that decomposes the 24-hour rhythm of heart rate into three parameters: the mesor, or midline level of the daily rhythm; the amplitude, or the size of its daily swing; and the phase, or the timing of its nightly trough.

The results fell into two strikingly different patterns. Across the full 30-day window, one signal emerged gradually: participants woke progressively earlier as the date of the pain record approached, with waketimes shifting by roughly 0.012 hours, about 43 seconds, per day. This trend reached statistical significance even after accounting for age and sex, though it weakened slightly when the researchers added a battery of confounders including comorbidity burden, opioid and gabapentinoid use, and histories of depression, anxiety, and sleep disorders. Bedtimes, sleep duration, and the timing of the heart rate rhythm showed no comparable gradual drift.

The second pattern was far more dramatic and appeared only in the final 48 hours before documentation. In that short window, both the amplitude and the mesor of the heart rate rhythm jumped significantly, by roughly 4.2 beats per minute each, while waketimes advanced by more than half an hour. In plain terms, patients’ hearts were beating with both a higher baseline and a larger daily swing, and they were rising earlier in the morning, right around the time their pain was being recorded in the medical chart. Crucially, these heart rate effects survived every robustness check the researchers threw at them, remaining essentially unchanged after adjustment for comorbidities and medications, and holding up across nearly the entire range of missing-data assumptions in sensitivity analyses.

What makes these findings genuinely surprising is what the researchers found when they ran the same analysis on a comparison group. They assembled a matched cohort of 98 surgical patients who never received a persistent pain diagnosis, assigning each an arbitrary reference date drawn from a routine, non-pain clinical encounter. None of the four signals appeared in this group. The gradual advance in waketime was absent, the near-record spikes in heart rate amplitude and mesor never materialized, and formal statistical tests confirmed that the time-by-cohort interactions were significant, meaning the physiological changes were specific to the persistent pain cohort rather than a generic feature of postoperative life or of medical visits in general.

The physiological interpretation is provocative. An elevated heart rate mesor and amplitude together suggest what the authors describe as a possible state of autonomic hyperactivation, an upregulation of the sympathetic nervous system that has long been documented in chronic pain conditions such as fibromyalgia. Just as intriguing is what did not change: the phase of the heart rate rhythm stayed fixed even as waketimes shifted earlier. This decoupling of the sleep timing system from the cardiac circadian system hints that the two oscillators, usually tightly entwined, may come apart in the run-up to persistent pain, and it points to heart rate rhythms specifically, rather than sleep timing alone, as the more promising candidate marker.

The researchers are careful about what the data can and cannot say. An electronic health record documents when pain was recorded, not when it began. The physiological changes in the days before documentation could reflect the true onset of persistent pain, a flare of pain that was already established, medication changes, or even the behavioral and administrative processes surrounding a patient’s decision to seek care. The authors argue that this imprecision would inject noise that blurs any true association, making the detection of systematic signals despite that noise all the more remarkable, but they emphasize that prospective studies with frequent, standardized pain assessments are needed to pin down the temporal relationship.

The study also offers an unusually candid lesson about the pitfalls of digital health research. The team attempted to build machine learning models to predict the timing of pain documentation from the wearable data, but discovered that model performance was inflated by a subtle artifact: wearable data completeness is itself systematically structured, with coverage dropping to about 65 percent on the day of a clinical record compared with 88 percent on other days. Missingness, in other words, carries information, and prediction models can exploit it for the wrong reasons. The researchers withheld those results and flagged the problem as a broader challenge for the field of electronic health record-anchored digital phenotyping.

Despite the caveats, the implications are considerable. Persistent postsurgical pain affects more than one in five adults with chronic pain overall, and sleep disturbance accompanies an estimated 75 percent of chronic non-cancer pain cases, yet clinical tools to identify at-risk patients before pain becomes entrenched remain elusive. If heart rate rhythm metrics from a device many people already wear on their wrists can flag a developing problem days in advance, clinicians could theoretically intervene earlier, adjusting pain management, sleep treatment, or rehabilitation before the condition consolidates. The authors caution that their cohort was modest, predominantly female, and drawn from a subset of patients with records meeting strict criteria, and that consumer wearables, while roughly 86 to 88 percent accurate for sleep-wake classification against polysomnography, vary across device models. Still, the study marks a compelling proof of concept: the body’s circadian machinery may broadcast the approach of chronic pain, and the devices to hear that broadcast are already on millions of wrists.

Subject of Research: Wearable-derived sleep and circadian heart rate features preceding persistent postsurgical pain documentation

Article Title: Wearable-derived sleep and circadian features associated with electronic health record-documented persistent postsurgical pain

Article References: Kim, R., Evanski, J. M., Smith, T., Forger, D. B., Kaplan, C., Clauw, D. J., & Whibley, D. (2026). Wearable-derived sleep and circadian features associated with electronic health record-documented persistent postsurgical pain. iScience, 29(11), Article 117930. https://doi.org/10.1016/j.isci.2026.117930

Image Credits: AI Generated

DOI: 10.1016/j.isci.2026.117930

Keywords: persistent postsurgical pain, wearables, Fitbit, circadian rhythms, heart rate, sleep, NIH All of Us, electronic health records, chronic pain, digital health, autonomic nervous system, iScience

The scale of the problem is enormous. According to data cited in the review from the World Health Organization, in 2022 approximately 2.5 billion adults were living with overweight, including more than 890 million adults with obesity. Projections suggest that by 2030 these numbers could rise to more than 2.9 billion adults with overweight and roughly 1.2 billion with obesity. The economic burden is equally staggering, with global costs associated with overweight and obesity expected to increase from approximately US$2 trillion in 2020 to more than US$3 trillion by 2030, potentially exceeding US$18 trillion by 2060. Beyond the numbers, obesity imposes a considerable clinical burden through its association with chronic low-grade inflammation, insulin resistance, type 2 diabetes, cardiovascular disease, and obstructive sleep apnea.

Sleep and circadian biology have assumed a central role in contemporary discussions of obesity etiology. Epidemiological and experimental evidence demonstrates that short sleep duration, poor sleep quality, irregular sleep-wake schedules, and circadian misalignment are associated with increased risk of obesity, insulin resistance, type 2 diabetes, and cardiovascular disease. The circadian timing system influences energy metabolism, appetite, glycemic homeostasis, hormone secretion, and eating behavior, thereby contributing to the development and maintenance of excess weight. Obstructive sleep apnea, highly prevalent in people with obesity, is associated with intermittent hypoxia, sleep fragmentation, oxidative stress, systemic inflammation, and sympathetic hyperactivity, all of which exacerbate the adverse metabolic effects of excess adiposity.

Physical exercise has emerged as a strategy capable of simultaneously acting on several of these interconnected mechanisms. In addition to its well-established effects on body composition, energy expenditure, and cardiorespiratory fitness, regular exercise may improve sleep quality, facilitate circadian synchronization, reduce inflammatory and oxidative stress markers, and promote beneficial autonomic and metabolic adaptations. The review emphasizes that exercise can act as a non-photic zeitgeber, influencing peripheral clocks, clock-gene expression, body temperature, hormonal rhythms, and metabolic responses, while conversely, circadian phase and individual chronotype may influence exercise performance and physiological responses.

At the molecular level, circadian rhythms are generated by a highly conserved transcriptional-translational feedback loop comprising core clock genes. The transcription factors CLOCK and BMAL1 form a heterodimer that activates the expression of Period and Cryptochrome genes, whose protein products subsequently inhibit CLOCK:BMAL1 activity, generating self-sustained oscillations with an approximately 24-hour periodicity. Clock genes regulate the rhythmic expression of numerous downstream genes involved in glucose metabolism, insulin signaling, lipid metabolism, mitochondrial function, and energy homeostasis. Alterations in clock gene expression or function have been associated with circadian disruption and increased risk of metabolic disorders, including obesity and type 2 diabetes. Exercise can modulate the expression of these clock genes, particularly in skeletal muscle, where an intrinsic circadian system temporally regulates metabolic pathways and cellular function.

The review highlights the emerging concept of chronoexercise, which suggests that the effects of exercise on metabolic health depend not only on its intensity, duration, and frequency but also on the time of day it is performed. Glucose tolerance, insulin sensitivity, and beta-cell responsiveness are generally higher in the morning and progressively decline throughout the day. Several studies have reported that exercise performed in the late afternoon or early evening is associated with greater improvements in glycemic control, insulin sensitivity, and lipid metabolism compared with morning exercise, particularly in individuals with overweight, obesity, or type 2 diabetes. Conversely, morning exercise may provide specific metabolic advantages, such as increased fat oxidation during fasted conditions. However, current evidence does not support a universally optimal time of day for exercise, and individual circadian characteristics, habitual exercise timing, and the alignment between training and performance should be considered when evaluating time-of-day effects.

Regarding neuroendocrine regulation, obesity can alter food-intake signaling, particularly through leptin resistance, which is commonly observed in individuals with obesity. Exercise can modulate appetite through physiological mechanisms that influence eating behavior and gastric motility and reduce hunger signals. Chronic exercise appears to reduce appetite and food intake and increase energy expenditure, potentially through mechanisms involving greater anorexigenic activity. Distinct effects on neuropeptides involved in food intake and satiety have been observed according to the acute or chronic effects of exercise, with longitudinal interventions in adolescents with obesity showing significant reductions in leptin and melanin-concentrating hormone. A recent meta-analysis demonstrated that individuals with overweight or obesity who engaged in regular exercise experienced reductions in body weight and body mass index, although across most studies ghrelin concentrations were increased or unchanged.

Exercise also promotes the conversion of white adipose tissue into beige adipose tissue through a process known as browning, which may contribute to increased energy expenditure. In obesity, metabolic alterations in white adipose tissue, primarily driven by adipocyte hypertrophy and hypoxia, promote adipose tissue dysfunction and increased secretion of pro-inflammatory mediators, including interleukin-6, tumor necrosis factor-alpha, and leptin, accompanied by reductions in anti-inflammatory markers such as adiponectin. Regular exercise can reduce pro-inflammatory biomarkers in obesity, and a meta-analysis reported that combined aerobic and resistance training was the most beneficial exercise modality for improving inflammatory markers and body composition in individuals with overweight or obesity compared with isolated aerobic exercise, resistance training, or high-intensity interval training.

The influence of exercise on sleep architecture is another critical dimension. One of the most consistent findings is an increase in slow-wave sleep, with meta-analytic evidence indicating that exercise significantly increases this restorative sleep stage. The effects on rapid eye movement sleep are less consistent, showing a tendency toward reduction, particularly in both acute and chronic intervention protocols. Exercise-induced thermoregulation may play a central role, as the elevation in body temperature during exercise may interact with the physiological decline in core body temperature that occurs during the evening and early night, a process important for sleep initiation. Sessions performed between 4 and 8 hours before bedtime appear more effective at increasing slow-wave sleep, while those conducted too close to bedtime may be detrimental. Beyond improving body composition and cardiovascular responses, exercise modulates the autonomic nervous system by increasing parasympathetic activity and reducing excessive sympathetic activity, with heart rate variability serving as a non-invasive marker of cardiac autonomic modulation that may represent a potential physiological link between exercise and sleep.

In the context of sleep-related breathing disorders, exercise has emerged as a promising non-pharmacological strategy to improve autonomic regulation through mechanisms that extend beyond weight loss alone. A randomized controlled trial implemented a six-month supervised concurrent exercise program consisting of moderate-intensity aerobic and resistance training performed three times per week, significantly improving metaboreflex control and attenuating exaggerated sympathetic responses in patients with obstructive sleep apnea. Another mechanism involves body fluid dynamics, as gravitational forces during prolonged sitting promote fluid accumulation in the lower limbs, which upon assuming the supine position during sleep is redistributed toward the neck, increasing peripharyngeal tissue volume and upper airway collapsibility. One week of moderate-intensity walking increased daily physical activity by approximately 80 percent, reduced overnight rostral fluid shift by 40 percent, and attenuated the reduction in pharyngeal air volume during sleep, adaptations accompanied by a 30 percent reduction in the apnea-hypopnea index without changes in body weight.

The review also addresses behavioral and psychological dimensions, noting that excess adiposity induces significant neurobiological alterations that modify brain circuits involved in regulating mood and eating behavior. Conversely, depressive and anxiety disorders may contribute to weight gain through hormonal alterations, reduced physical activity, changes in eating behavior, and impaired sleep quality, establishing a reciprocal and self-perpetuating relationship. Chronotype and social jetlag, reflecting individual differences in preferred timing and misalignment between biological and socially imposed schedules, have been associated with obesity and adverse metabolic outcomes. Evening chronotypes have also been associated with lower levels of physical activity and greater sedentary behavior, suggesting that circadian preferences may influence engagement in regular exercise.

Despite the growing consistency of evidence supporting beneficial effects of exercise on sleep, circadian rhythms, mental health, and metabolic regulation, important knowledge gaps remain. Questions regarding the most effective exercise modality, intensity, duration, frequency, and particularly the timing of exercise remain incompletely answered. Accumulating evidence suggests there is unlikely to be a single optimal exercise prescription applicable to all individuals, with considerable interindividual variability in physiological and clinical responses influenced by intrinsic factors including age, sex, chronotype, genetic background, baseline physical fitness, and metabolic status, and extrinsic factors such as exercise timing, modality, intensity, sleep habits, dietary patterns, medication use, and environmental influences.

Individuals with obesity frequently face individual, social, and environmental barriers to initiating and maintaining a training routine, including obesity-related comorbidities, low motivation, difficulties with adherence, pain and physical discomfort, fatigue, lack of time, and limited social support. Environmental barriers such as limited access to suitable facilities, neighborhood insecurity, and lack of professional guidance can also reduce exercise levels in this population. Conversely, improvements in physical fitness, physical and mental wellbeing, and perceived pleasure during exercise have been associated with higher levels of physical activity, while resilience and realistic expectations regarding outcomes may also contribute to greater engagement.

The review concludes that physical exercise represents a key non-pharmacological strategy for the prevention and management of obesity, with benefits extending to metabolic health, sleep, and circadian regulation. Its effects depend not only on exercise type, intensity, and duration but may also be influenced by exercise timing and individual characteristics, including chronotype, sleep patterns, social jetlag, metabolic status, and behavioral context. The concept of chronoexercise expands the traditional approach to exercise prescription by incorporating its temporal dimension and interactions with other important circadian synchronizers, such as the light-dark cycle and meal timing. Although longitudinal studies and clinical trials are still needed to establish causal relationships and define more precise timing strategies, integrating exercise, sleep, and circadian biology offers a promising framework for more individualized interventions that may improve adherence and maximize sustainable benefits for the prevention and management of obesity and its associated metabolic and sleep disturbances.

Subject of Research: Health & Medicine

Article Title: Physical exercise as a modulator of the sleep–obesity interaction: metabolic, neuroendocrine and circadian mechanisms

Article References: Campos, R. M. S., de Sá Souza, H., Favaron, C. M., Saborosa, G. P., Ferez, L. C., Tufik, S., Antunes, H. K. M., D'Almeida, V., & Mônico-Neto, M. (2026). Physical exercise as a modulator of the sleep–obesity interaction: metabolic, neuroendocrine and circadian mechanisms. Frontiers in Sleep, 5, Article 1943600. https://doi.org/10.3389/frsle.2026.1943600

Image Credits: AI Generated

DOI: 10.3389/frsle.2026.1943600

Keywords: obesity, sleep, circadian rhythms, physical exercise, chronoexercise, metabolism, neuroendocrine, inflammation, sleep apnea, Frontiers in Sleep, Physical, exercise

Researchers at the University of California, Davis, led by Sara K. Pintwala and Patrick M. Fuller, used single-nucleus RNA sequencing to profile individual neurons from the lateral hypothalamus of adult female and male mice. The technique captures the complete transcriptome — the full inventory of genes being actively read — from thousands of individual cell nuclei at once. Tissue was collected precisely at the onset of the dark phase, zeitgeber time 12, a biologically charged moment when nocturnal animals transition from rest to activity and when competing drives like feeding, exploration, and wakefulness surge together.

The team sequenced more than 85,000 nuclei in total, ultimately isolating 33,235 high-quality neuronal nuclei — 16,432 from females and 16,803 from males. After correcting for ambient RNA contamination, removing doublets, and integrating the datasets to control for batch effects, the researchers asked a deceptively simple question: do male and female lateral hypothalamic neurons differ in the genes that build and receive circadian signals?

The first surprise was what they did not find. When the researchers clustered all the nuclei together using unsupervised computational methods, the analysis revealed 24 distinct neuronal clusters — and every single one contained cells from both sexes. There was no evidence of sex-specific neuron classes, and the relative proportions of major cell types were nearly identical between males and females. Glutamatergic, GABAergic, orexin-producing, and melanin-concentrating hormone-associated populations were all represented at matching ratios, with odds ratios hovering close to 1.0. Structurally, the male and female lateral hypothalamus looked like the same brain region.

But beneath that conserved architecture, the molecular machinery told a different story. The researchers focused on a curated panel of clock and circadian signaling genes: the core activators Clock, Arntl (which encodes BMAL1), and Npas2; the repressors Per1, Per2, Per3, Cry1, and Cry2; auxiliary regulators such as Nr1d1, Nr1d2, and the ROR family; and receptors for the suprachiasmatic nucleus’s signature neuropeptides, including vasoactive intestinal peptide (VIP), arginine vasopressin (AVP), gastrin-releasing peptide, neuromedin S, cholecystokinin, and melatonin. Differential expression testing, corrected for false discovery, uncovered 15 genes whose expression differed significantly between the sexes.

The pattern of those differences was strikingly coherent. Female-derived neurons were enriched for the vasopressin receptor Avpr1a, the melatonin receptor Mtnr1b, the clock repressors Per2 and Per3, and the auxiliary regulators Nr1d1, Nr1d2, and Rora. Male-derived neurons, by contrast, showed enrichment for the VIP receptor Vipr2, along with Nmur2 and Cckar — receptors for neuromedin and cholecystokinin signaling — and, notably, for the core positive-limb oscillator genes Clock, Npas2, and Arntl, plus Per1, Cry1, and Rorb. In other words, the two sexes appeared to weight different limbs of the same circadian feedback loop, and different neuromodulatory input channels, across shared neuronal populations.

These motifs repeated across cell types. In glutamatergic neurons, females preferentially expressed AVP and melatonin-related transcripts while males emphasized VIP and CCK receptors alongside Npas2 and Clock. In GABAergic neurons, female enrichment again centered on Nr1d2, Per2, Per3, Rora, and the melatonin receptor Mtnr1a, while males showed elevated Nmur2, Rorb, Vipr2, Per1, Cry1, Arntl, and Clock. Among the peptidergic populations, differences were subtler but still present: Npas2 was enriched in female orexin neurons, while male melanin-concentrating hormone neurons showed enrichment for Rora, Cry1, Arntl, Npas2, and Mtnr1a. The consistency across excitatory, inhibitory, and neuropeptide-specific populations suggests a coordinated, system-level shift in how temporal information is processed, rather than random noise.

The functional implications are considerable. AVP signaling from the suprachiasmatic nucleus is a principal conduit of circadian output, critical for synchrony and phase regulation, while VIP is essential for keeping pacemaker neurons firing in unison. Neuromedin S-producing neurons act as pacemakers that couple clock cells across the circadian network, and cholecystokinin pathways have been implicated in circadian adaptation under changing photoperiods. If female lateral hypothalamic neurons are transcriptionally primed to receive vasopressin-dominant signals while male neurons favor VIP, neuromedin, and CCK inputs, then the same upstream timing information from the master clock could be translated into different downstream behavioral and physiological outputs in each sex — different thresholds for arousal, feeding, stress responsiveness, and sleep-wake transitions at the same time of day.

The study also mapped sex hormone receptor expression across all lateral hypothalamic neuron types, finding that androgen receptor transcripts were most abundant, estrogen receptor 1 moderate, and estrogen receptor 2 lowest, in both sexes. Because estrogen receptor 1 functions as a ligand-activated transcription factor known to drive expression of Per2 and Clock in hypothalamic neurons, its widespread presence identifies a concrete molecular route through which circulating steroids could reshape circadian transcription in a sex-dependent manner. This aligns with earlier work showing that androgens alter the magnitude of light-induced phase shifts and that estrogen signaling stabilizes firing synchrony in the suprachiasmatic nucleus.

The authors are careful about what their data can and cannot show. Because tissue was sampled at a single circadian timepoint in gonad-intact animals without estrous-cycle staging, the findings cannot establish whether the observed differences reflect stable sex dimorphism, fluctuating endocrine state, circadian phase, or interactions among all three. Nor can a snapshot at dark-phase onset reveal oscillatory amplitude or phase relationships across the full 24-hour cycle. What the study does establish is a framework: sexual dimorphism in the lateral hypothalamus emerges not through fundamentally distinct neuronal populations but through subtle, reproducible, and coordinated shifts in molecular signaling architecture — a differential tuning of shared circuits. As circadian and sleep medicine increasingly confront sex differences in rhythm period, amplitude, and disease vulnerability, the message is clear: the same clock may tick in everyone, but males and females may hear it through different molecular ears.

Subject of Research: Sex differences in circadian clock gene and neuropeptide receptor expression in the lateral hypothalamus

Article Title: Sex-associated circadian signaling signatures in the lateral hypothalamus

Article References: Pintwala, S. K., & Fuller, P. M. (2026). Sex-associated circadian signaling signatures in the lateral hypothalamus. Frontiers in Sleep, 5, 1895831. https://doi.org/10.3389/frsle.2026.1895831

Image Credits: AI Generated

DOI: 10.3389/frsle.2026.1895831

Keywords: lateral hypothalamus, circadian rhythms, single-nucleus RNA sequencing, sex differences, suprachiasmatic nucleus, orexin neurons, melanin-concentrating hormone, vasoactive intestinal peptide, arginine vasopressin, clock genes, hypothalamus, sleep-wake regulation

But a new Debate article published in BMC Medicine by chronobiologist Manuel Spitschan and Johannes Zauner, both of the Technical University of Munich, argues that the field is standing on a measurement problem it has barely begun to confront. Their central claim is deceptively simple: not all light exposure measures are equal. Satellite-derived night-time radiance, wrist-worn illuminance readings, bedroom light levels, light measured at the cornea, retinal exposure after optical and pupillary modulation, and modelled circadian stimulus are all related, but they are not interchangeable. Each one captures a different construct, and each construct supports different kinds of scientific inference.

The crux of the argument lies in a question that sounds almost philosophical but has hard practical consequences: what light exposure construct is actually being measured, and how closely does it correspond to the biologically relevant stimulus arriving at the eye and the retina? The human circadian system does not respond to light in the environment in the abstract. It responds to photons striking a specific class of retinal cells, the intrinsically photosensitive retinal ganglion cells, which are most sensitive to a portion of the blue-cyan spectrum. The signal those cells send to the brain’s master clock depends on the spectral composition, intensity, timing and duration of light reaching the retina, which in turn depends on everything between the light source and the photoreceptor: windows, eyeglasses, eyelids, head orientation and the pupil itself.

Consider what a satellite actually measures. Satellites capture upward-directed radiance from the Earth’s surface at night, a proxy for outdoor artificial lighting in a neighbourhood. That measure says nothing about how much light enters a person’s eyes while they sit indoors, sleep behind blackout curtains, or walk down a lit street. A wrist-worn light sensor, by contrast, records illumination at the wrist, which can diverge dramatically from light at the eye depending on body posture, clothing and activity. Bedroom illuminance meters capture only one micro-environment in a 24-hour cycle. Each of these scalable proxies has enabled research at population scale that no laboratory study could ever achieve, but each carries its own uncertainty about what it truly represents.

Spitschan and Zauner do not argue that these scalable measures should be abandoned. On the contrary, they acknowledge that such tools have delivered evidence at scales impossible in laboratory or small field studies, and they have raised the visibility of light within population health research. The central challenge, as they frame it, is not whether proxies should be used, but how their meaning, uncertainty and relationship to actual ocular exposure can be specified and empirically quantified. A satellite pixel can be a perfectly legitimate exposure measure for a question about community-level outdoor lighting, and a wrist sensor can be legitimate for a question about behavioural light patterns, but conflating these constructs with retinal light exposure invites misinterpretation.

To address this, the authors propose a construct-centred framework for the next phase of light epidemiology. The framework rests on three pillars. First, researchers should explicitly define the exposure construct they intend to measure, stating precisely what physical quantity, at what anatomical location, over what time window, their instrument captures. Second, measures should be validated across measurement sites and spatial scales, so that the relationship between a proxy such as satellite radiance or wrist illuminance and the gold standard of corneal or retinal exposure is empirically characterised rather than assumed. Third, studies should pre-specify causal models that link behavioural determinants, 24-hour light-dark exposure, biological pathways, intermediate phenotypes and clinical outcomes, making the chain of inference explicit before data are collected.

The emphasis on pre-specified causal models reflects a broader concern about how light-health associations are interpreted. When a study reports that people living in brighter neighbourhoods at night have higher rates of a particular disease, the exposure is a neighbourhood-level proxy filtered through countless individual behaviours: time spent outdoors, window coverage, screen use, sleep timing, occupation and socioeconomic circumstances. Without a pre-specified model of how the measured construct relates to the biologically relevant stimulus and to potential confounders, such associations remain difficult to interpret causally. The framework is designed to move the field from broad associations towards mechanistically informed evidence that can actually support interventions.

The technical vocabulary of the field illustrates why construct clarity matters. Melanopic equivalent daylight illuminance, a metric standardised through the International Commission on Illumination, quantifies light in terms of its effectiveness for the melanopsin-containing photoreceptors that drive non-visual responses. It is a physiologically grounded quantity, but computing it requires spectral information that many wearable devices do not capture. Modelled circadian stimulus goes further, incorporating the nonlinear temporal integration properties of the circadian system. These refined constructs sit at one end of a spectrum; coarse but scalable proxies sit at the other. The authors argue that both ends have value, provided researchers are explicit about which construct they are measuring and what inferences it can legitimately support.

The paper also draws on validation work conducted under the European metrology project MeLiDos, which focuses on metrology for wearable light loggers and optical radiation dosimeters. Participant data illustrated in the article derive from previously conducted studies approved by the Medical Ethics Committee of the Technical University of Munich and by ethics committees at participating MeLiDos sites, with all participants providing written informed consent. This kind of multi-site validation, the authors contend, is exactly what the field needs more of: systematic characterisation of how well different instruments and proxies agree, and quantification of the uncertainty that propagates from measurement to inference.

The stakes extend beyond academic rigour. If light exposure is genuinely a modifiable health determinant, then eventually the field will be asked to produce actionable guidance, much as it has for sleep, diet and physical activity. Recommendations about daytime brightness, evening dimming and night-time darkness can only be as good as the exposure science underneath them. A framework that distinguishes constructs, validates proxies against ocular exposure and embeds measurement in explicit causal models is, in the authors’ view, the route to translationally useful evidence. Their stated goal is to support the integration of high-throughput epidemiology with physiologically interpretable measurement, enabling light epidemiology to mature from an era of discovery into an era of mechanism and intervention. As wearables proliferate and satellite data grow ever finer, the question of what exactly is being measured when we measure light may determine whether the field’s promise is realised.

Subject of Research: Exposure assessment and causal inference methodology in light epidemiology

Article Title: Not all light exposure measures are equal: a framework for exposure assessment and causal inference in light epidemiology

Article References: Spitschan, M., & Zauner, J. (2026). Not all light exposure measures are equal: a framework for exposure assessment and causal inference in light epidemiology. BMC Medicine. https://doi.org/10.1186/s12916-026-05259-z

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05259-z

Keywords: light exposure, environmental epidemiology, exposure assessment, causal inference, circadian rhythms, wearable sensors, ocular light exposure, melanopic equivalent daylight illuminance, measurement validation, satellite radiance, retinal exposure, public health

The research team, led by investigators at the University of Murcia in Spain together with collaborators at Harvard Medical School, Massachusetts General Hospital and the University of Colorado Boulder, recruited 809 healthy adults of European descent from the Spanish ONTIME-MT cohort, a study registered with ClinicalTrials.gov under number NCT03036592. The participants, whose average age was about 37 years and roughly 71 percent of whom were women, wore sensors for seven consecutive days while going about their ordinary lives. Light exposure was recorded continuously, and so was wrist temperature, a surprisingly informative physiological signal that rises during rest and sleep as blood flows back toward the skin and falls during activity and wakefulness. Rather than examining each rhythm metric in isolation, the researchers used principal component analysis, a statistical technique that compresses many correlated variables into a small number of composite factors, to capture the overall architecture of each person’s circadian functioning.

The analysis produced three factors in each of the two domains, light exposure and wrist temperature, and together these factors explained roughly 73 percent of the variance in light rhythms and 80 percent of the variance in temperature rhythms. In both domains, the first factor carried the greatest weight, accounting for about 41 to 42 percent of the variance. This dominant factor reflected what the researchers call rhythm robustness: a combination of high relative amplitude, meaning a large difference between the peaks and troughs of the daily cycle, and greater interdaily stability, meaning the rhythm repeats reliably from one day to the next, along with the person’s average levels of light exposure or wrist temperature. In practical terms, a person scoring high on this factor lived a life of bright days, dark nights and a body temperature rhythm that rose and fell like clockwork, day after day.

What happened when those robustness scores were matched against blood tests and body measurements was the heart of the study. People with stronger, more stable light exposure rhythms had lower serum triglyceride concentrations, a relationship that reached statistical significance at P equals 0.013. Triglycerides are fats circulating in the blood, and elevated levels are a well-established marker of cardiovascular risk. The association between light and blood fats is biologically plausible: light is the primary external synchronizer of the circadian system, and laboratory work has shown that when the circadian clock is misaligned with behavioral cycles, glucose tolerance, insulin sensitivity and lipid metabolism all deteriorate. Animal studies have gone further, showing that light at night can increase body mass partly by shifting the timing of food intake into hours when the metabolism is poorly prepared for it.

The wrist temperature results were, if anything, even more compelling. Higher wrist temperature Factor 1, the robustness composite, was associated with lower body mass index and lower body fat percentage in women, as well as lower fasting insulin, lower HOMA-IR, a standard index of insulin resistance calculated from glucose and insulin levels, lower triglycerides and higher HDL cholesterol, the so-called good cholesterol. All of these associations were statistically significant at P values below 0.05. Wrist temperature is an integrated readout of the circadian system because it reflects the interplay between the autonomic nervous system, vascular tone and the master clock in the hypothalamus. Previous work by some of the same investigators had shown that obese women display flatter, less rhythmic wrist temperature profiles than normal-weight women, and the new study extends that observation to a much larger sample and ties it directly to a panel of metabolic risk markers.

Perhaps the most intriguing finding came from the mediation analyses, which probed whether the two rhythm domains influence each other in a way that shapes metabolic outcomes. The results suggested that the interdaily stability of wrist temperature rhythms may act as a conduit in the relationship between light exposure stability and triglyceride levels, accounting for approximately 11 percent of the total effect, with a P value of 0.021. In other words, part of the reason that well-structured light exposure is associated with healthier blood fats may be that stable light patterns help stabilize the body’s internal temperature rhythm, which in turn supports healthier lipid metabolism. This kind of chained relationship, from environmental signal to physiological rhythm to metabolic outcome, is exactly what circadian theory would predict, but demonstrating it in free-living humans with real-world sensor data is rare.

The study’s design carries important caveats. It was cross-sectional, meaning that light, temperature and metabolic markers were all measured at roughly the same time, so the direction of causality cannot be established with certainty. It is entirely possible that people with healthier metabolisms simply live more regular lives, or that obesity itself flattens circadian rhythms rather than the other way around. The cohort consisted of healthy adults of European descent from a single Spanish population, which limits generalizability to other ethnic groups and to people with existing metabolic disease. The authors are careful on this point: the findings show consistent associations, not proof that stabilizing your rhythms will lower your triglycerides. Still, the consistency of the pattern across two independent physiological domains, and the dose-response-like structure revealed by the principal component analysis, strengthens the case that rhythm robustness is genuinely informative rather than statistical noise.

The broader context makes these results timely. A landmark 2024 analysis of more than 88,000 people wearing light sensors found that brighter nights and darker days predicted higher mortality risk, and a growing literature links circadian disruption, from shift work to evening chronotypes to social jet lag, with cardiometabolic disease. Controlled laboratory experiments by Frank Scheer and colleagues, a co-author on the new paper, have shown that forced circadian misalignment in humans raises glucose and insulin levels and blood pressure within days. What the ONTIME-MT study adds is a demonstration that these relationships are visible in ordinary people, in their own homes, using nothing more than a week of passive wrist-worn monitoring and a well-chosen statistical framework.

The practical implications are twofold. First, the study highlights the potential of circadian-related markers derived from wearable technologies as non-invasive indicators of metabolic risk. Instead of relying solely on blood draws taken at a single moment, clinicians of the future might read a week of light and temperature actigraphy to gauge how robustly a patient’s internal clocks are running, and use that information to identify people who would benefit from lifestyle interventions. Second, it points toward concrete behavioral targets: brighter light during the day, darker environments at night, and daily routines regular enough to keep the body’s temperature rhythm oscillating with a strong, reliable beat. None of this replaces diet and exercise, but it suggests a third pillar of metabolic health that has been hiding in plain sight, glowing on our screens and pulsing quietly at our wrists. As wearable sensors become ubiquitous, the science of chronodisruption is moving from the laboratory bench to the population scale, and the body’s daily rhythms are emerging as a vital sign in their own right.

Subject of Research: Associations between daily light exposure and wrist temperature circadian rhythms and metabolic risk markers in healthy adults

Article Title: Disrupted daily rhythms in light exposure and wrist temperature are associated with metabolic risk markers and obesity

Article References: Dozzani, I., Rodríguez-Martín, M., Dashti, H. S., Vetter, C., Fernández-Breis, J. T., Florez, J. C., Saxena, R., Scheer, F. A. J. L., & Garaulet, M. (2026). Disrupted daily rhythms in light exposure and wrist temperature are associated with metabolic risk markers and obesity. International Journal of Obesity. https://doi.org/10.1038/s41366-026-02225-w

Image Credits: AI Generated

DOI: 10.1038/s41366-026-02225-w

Keywords: circadian rhythms, light exposure, wrist temperature, obesity, metabolic risk, triglycerides, insulin resistance, wearables, chronobiology, HOMA-IR, interdaily stability, ONTIME-MT

Frontotemporal dementia is an umbrella term covering several clinically distinct syndromes that share a common target: the frontal and temporal lobes of the brain. While the behavioural variant, marked by apathy, disinhibition, and loss of empathy, is the most widely recognised form, the temporal lobe variants present a different and often deceptive picture. The left-sided temporal variant, known as semantic variant primary progressive aphasia, erodes the patient’s knowledge of words, objects, and meanings, producing profound language difficulties while leaving other cognitive faculties relatively intact for years. The right-sided temporal variant, sometimes described in the literature as right temporal lobe atrophy, is even more elusive, producing subtle changes in personality, social conduct, and emotional processing that can be mistaken for psychiatric illness for years before a neurological diagnosis is made.

These syndromes have long been studied through the lens of language and behaviour, but a growing body of evidence suggests that sleep may offer an equally revealing window into the underlying disease. Previous work has documented sleep disturbances across the frontotemporal dementia spectrum, and researchers have proposed that the orexin system, a neuropeptide network in the hypothalamus that governs arousal and wakefulness, may be a key player. Studies have reported reduced orexin-A levels in patients with frontotemporal dementia, and a possible association between this loss and the severity of sleep disruption. More recently, investigators have linked changes in cerebral and hypothalamic structure to sleep dysfunction in people with genetic forms of the disease, raising the possibility that the hypothalamus, the brain’s master clock, is drawn into the neurodegenerative process earlier than previously appreciated.

The UCL-led study set out to address a conspicuous gap in this literature. Although sleep symptoms have been characterised in the behavioural variant of frontotemporal dementia and in Alzheimer’s disease, the temporal lobe variants have been largely overlooked, despite their distinctive pattern of brain atrophy. The research brought together a carefully characterised patient cohort from the Dementia Research Centre, where patients undergo detailed clinical, neuropsychological, and imaging assessment, and combined this clinical expertise with the sleep science methodology of the Surrey Sleep Research Centre, one of the United Kingdom’s leading centres for the study of human sleep and circadian rhythms.

Technically, the investigation relied on validated subjective sleep instruments, most notably the Pittsburgh Sleep Quality Index, a questionnaire widely regarded as the gold standard for capturing the multidimensional nature of sleep quality, spanning sleep duration, latency, disturbances, efficiency, and daytime dysfunction. The team also employed the Epworth Sleepiness Scale, a measure of generalised daytime sleepiness that quantifies the propensity to doze in everyday situations such as reading, watching television, or sitting in conversation. By applying these standardised tools to patients with temporal lobe variants, the researchers could characterise sleep disturbance in a way that is comparable with the wider dementia literature, allowing direct comparison with previous findings in behavioural variant frontotemporal dementia and Alzheimer’s disease.

The rationale for this approach is grounded in a broader conceptual shift in neurodegeneration research. Rather than viewing sleep disturbance as a mere consequence of dementia, an increasing number of researchers argue that sleep and circadian disruption may be intertwined with the disease process itself, potentially reflecting the spread of pathological protein deposits into sleep-regulating circuitry. In Alzheimer’s disease, excessive daytime napping has been linked to dementia risk in what may be a bidirectional relationship, with poor sleep promoting the accumulation of amyloid and amyloid pathology in turn fragmenting sleep. Whether a similar reciprocal dynamic operates in frontotemporal dementia remains an open question, but the involvement of the hypothalamus and the orexin system provides a plausible mechanistic bridge between temporal lobe degeneration and disordered arousal.

The temporal lobes themselves are not passive bystanders in this story. Anatomical studies have shown that the anterior and medial temporal structures, including the amygdala and hippocampus, are densely connected with hypothalamic and brainstem arousal systems, and that atrophy in these regions reshapes the networks that govern emotional and physiological states. In semantic variant primary progressive aphasia, tissue loss typically begins in the left anterior temporal lobe and progresses asymmetrically, while right temporal variant disease mirrors this pattern on the opposite side. Because these variants damage the temporal lobes in a relatively focal and lateralised fashion, they offer neurologists a natural experiment: by comparing sleep profiles across left- and right-predominant disease, researchers can begin to map which aspects of sleep regulation are tied to which temporal networks.

The clinical implications of characterising sleep disturbance in these patients are considerable. Sleep problems are among the most burdensome symptoms for family caregivers, frequently precipitating care home admission and compounding the behavioural symptoms that already strain daily life. If sleep disruption in temporal lobe variants follows a recognisable clinical signature, clinicians could screen for it systematically, counsel families proactively, and potentially intervene with targeted behavioural or pharmacological strategies. Moreover, because sleep symptoms may emerge early in the disease course, as has been suggested for the behavioural variant in recent polysomnographic work documenting altered nocturnal sleep dynamics in early-stage patients, they could serve as diagnostic clues in cases where the temporal variant syndrome is still masquerading as a primary psychiatric or language disorder.

The study also reflects a wider trend toward interdisciplinary collaboration in dementia research. The partnership between the UCL Dementia Research Centre, with its decades of expertise in rare dementia syndromes, and the Surrey Sleep Research Centre, with its deep methodological grounding in circadian physiology, exemplifies the kind of cross-disciplinary approach that the field increasingly demands. The work was supported by Alzheimer’s Research UK, the Alzheimer’s Society, the Royal National Institute for Deaf People, and the National Institute for Health and Care Research University College London Hospitals Biomedical Research Centre, alongside a Frontotemporal Dementia Research Studentship funded through The National Brain Appeal. The authors, including joint senior authors Jason D. Warren and Jessica Jiang, report no conflicts of interest, and the study received ethical approval from the joint research ethics committees of University College London, the University of Surrey, and the National Hospital for Neurology and Neurosurgery, with all participating patients giving written informed consent.

For patients and families affected by these rare temporal lobe dementias, the message is one of cautious optimism. Sleep, long relegated to the margins of the clinical conversation, is now being taken seriously as a core feature of the disease, one that may illuminate both the mechanisms of neurodegeneration and the practical realities of daily care. As the evidence base grows, the hope is that a better understanding of sleep disturbance in temporal lobe variants of frontotemporal dementia will translate into earlier diagnosis, more comprehensive symptom management, and, ultimately, therapies that target the sleep-regulating circuits caught in the path of the disease. The full findings are published in the Journal of Neurology, and the datasets generated during the study are available from the corresponding author in anonymised form on reasonable request, in keeping with the ethical and confidentiality requirements that govern research with this vulnerable patient population.

Subject of Research: Sleep disturbance in temporal lobe variants of frontotemporal dementia

Article Title: Clinical features of sleep disturbance in temporal lobe variants of frontotemporal dementia

Article References: Larsen, E. K., Levett, B. A., Core, L. B., della Monica, C., Hassanin, H., Atzori, G., Harding, E., Dijk, D.-J., Revell, V. L., Eriksson, S. H., Rohrer, J. D., Warren, J. D., & Jiang, J. (2026). Clinical features of sleep disturbance in temporal lobe variants of frontotemporal dementia. Journal of Neurology, 273(9), Article 558. https://doi.org/10.1007/s00415-026-14104-5

Image Credits: AI Generated

DOI: 10.1007/s00415-026-14104-5

Keywords: frontotemporal dementia, sleep disturbance, temporal lobe atrophy, semantic variant primary progressive aphasia, orexin, hypothalamus, Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, neurodegeneration, circadian rhythms, dementia care, Journal of Neurology

The researchers approached the problem by building a compartmentalized mathematical model of the suprachiasmatic nucleus, one that explicitly incorporates the heat shock protein pathway alongside the core circadian oscillator. Heat shock proteins are molecular chaperones that cells deploy when temperatures rise, and they interact with clock gene networks in ways that can alter the timing of molecular feedback loops. By embedding this thermal response machinery into a network model of the suprachiasmatic nucleus, the team could simulate how the entire structure reacts when heat stimuli arrive. The goal was not merely to reproduce known behavior but to identify which features of the network’s organization are responsible for its remarkable temperature resistance.

The model’s first test was to recapitulate a striking experimental observation: heat stimuli can entrain peripheral clocks to an inverted phase, meaning the peripheral oscillator locks onto the thermal cycle in a phase relationship opposite to what might be expected, while the suprachiasmatic nucleus maintains its normal phase and resists entrainment altogether. When the researchers ran their simulations, the compartmentalized model successfully reproduced both behaviors. Peripheral-like oscillators shifted as experiments show they should, and the modeled suprachiasmatic nucleus held its ground. This dual success was critical, because it suggested the model had captured the essential ingredients that distinguish central from peripheral temperature responses, rather than merely fitting one behavior at the expense of the other.

With a model that behaved like the biological system, the team could then interrogate it in ways no experiment easily allows. The key insight that emerged concerns phase heterogeneity within the suprachiasmatic nucleus itself. The structure is not a homogeneous blob of synchronized neurons. Its subregions, most notably the dorsal and ventral compartments, run their circadian oscillators at slightly different phases, a well-documented feature of the real nucleus. The simulations revealed that this intrinsic phase difference is not incidental. It is the engine of temperature resistance. When a heat stimulus hits the entire nucleus at once, the dorsal and ventral regions respond to the thermal input from their different starting phases, and their individual phase shifts pull in divergent directions.

The consequence of this divergence is an attenuated net shift of the overall suprachiasmatic nucleus phase. In other words, the two subregions partially cancel each other out. Where a peripheral tissue, acting as a single relatively uniform oscillator, would shift its phase substantially in response to a thermal cycle, the suprachiasmatic nucleus absorbs the same input and produces only a small net change because its internal components are pulling against one another. Temperature resistance, in this view, is not a property of individual suprachiasmatic neurons, whose molecular clocks resemble those of peripheral cells, but an emergent property of the network’s spatial organization.

The researchers also examined the mode of thermal input and found a second layer of robustness. In the natural situation, thermal stimulation reaches the dorsal and ventral regions concurrently, and the model indicates that this simultaneous stimulation may actively enhance the nucleus’s resistance to temperature entrainment. Because both compartments are pushed at the same moment from their offset phases, the opposing phase responses are maximally aligned against each other, reinforcing the cancellation effect. Had the thermal input arrived in a pattern that preferentially engaged one subregion at a time, the protective cancellation would presumably be weaker. This suggests that the way the body delivers thermal information to the nucleus, not just the way the nucleus is built, contributes to its stability.

One of the most intriguing implications of the work concerns how temperature entrainment resistance compares with the better-studied phenomenon of photic entrainment. Light resets the suprachiasmatic nucleus through the retinohypothalamic tract, a dedicated neural pathway that delivers photic information in a spatially and temporally structured way, and the nucleus integrates that input to track the day-night cycle. The new results suggest that the mechanisms guarding against temperature entrainment are mechanistically distinct from those governing light entrainment. The nucleus does not resist heat because it lacks the molecular machinery to respond; individual cells almost certainly possess it. It resists because of how the network is wired and phased. This distinction matters for anyone modeling circadian biology, because it means the rules that apply to light cannot simply be transplanted to temperature.

The study also reframes the long-standing question of why peripheral tissues are so temperature sensitive. From an evolutionary standpoint, a liver or kidney that can align its metabolic rhythms with daily thermal fluctuations may gain a functional advantage, fine-tuning enzyme activity and metabolic flux to the body’s thermal environment. The master clock, by contrast, must remain stable precisely because it coordinates all the peripheral oscillators. If the conductor of the orchestra were swayed by every passing temperature change, the entire circadian system would lose coherence. The compartmentalized architecture of the suprachiasmatic nucleus, with its phase-offset subregions, appears to be a design solution to this stability problem, allowing the central pacemaker to filter out thermal noise while remaining exquisitely sensitive to light.

Technically, the achievement rests on the integration of the heat shock protein pathway into a compartmentalized circadian model, a coupling that had not been systematically explored at the network level for the suprachiasmatic nucleus. Heat shock proteins respond to temperature elevation by altering the availability and activity of proteins within the clock’s transcriptional-translational feedback loops, effectively changing the parameters of the oscillator in a temperature-dependent manner. By representing the nucleus as distinct compartments with defined phase relationships and shared thermal input, the model could capture how a stimulus that would strongly shift a single oscillator produces only a weak net effect across the coupled network. The fidelity of the model to experimental observations, including the inverted phase entrainment seen in peripheral clocks, lends credibility to the mechanistic claims that follow from the simulations.

The broader significance of this work extends beyond circadian biology into the general principles of robust biological networks. It demonstrates that resistance to an external forcing signal can arise not from insensitivity at the component level but from structured heterogeneity across a network, a principle with echoes in neural circuits, gene regulatory systems, and engineered control systems alike. For circadian researchers, the model generates testable predictions: disrupting the phase relationships between dorsal and ventral subregions, or altering the spatial pattern of thermal input, should weaken the nucleus’s temperature resistance in measurable ways. For the wider public, the study offers a satisfying answer to a deceptively simple question. The reason a feverish day or a hot afternoon does not scramble your body’s master schedule is that the brain’s clock is not one clock but a carefully phased assembly of clocks, built so that its parts hold each other in place when the heat tries to push them around.

Subject of Research: Computational modeling of temperature entrainment resistance in the mammalian suprachiasmatic nucleus circadian clock

Article Title: A compartmentalized SCN model explains temperature resistance through interregional phase differences

Article References: Yu, F., Yang, L., & Yan, J. (2026). A compartmentalized SCN model explains temperature resistance through interregional phase differences. PLOS Computational Biology, 22(9), e1014831. https://doi.org/10.1371/journal.pcbi.1014831

Image Credits: AI Generated

DOI: 10.1371/journal.pcbi.1014831

Keywords: circadian rhythms, suprachiasmatic nucleus, temperature entrainment, heat shock proteins, computational biology, phase heterogeneity, dorsal SCN, ventral SCN, peripheral clocks, PLOS Computational Biology, circadian stability, systems biology

The study, led by Henok Mulatu Teferi of Emory University’s Rollins School of Public Health together with co-first author Gina Marie Mathew of Stony Brook University and colleagues, analyzed data from 406 ninth graders enrolled at two racially and ethnically diverse high schools. Ninth grade is a pivotal year in the American education system; it marks the transition into courses that count toward graduation and a period when absenteeism patterns can harden into chronic disengagement. Prior research has documented racial and ethnic disparities in both grade point averages and school absences, and a large body of work links sleep, in terms of its duration, timing, and quality, to how well adolescents perform in school. What remained unclear was whether sleep differences between groups actually account for a meaningful share of the achievement and attendance gaps.

To answer that question, the researchers employed counterfactual-based mediation analysis, a statistical framework that asks how much of the total effect of an exposure on an outcome flows through an intermediate variable, the mediator. In this case, race and ethnicity, categorized as Asian, Black, Hispanic, or White, served as the exposure. Two sleep measures acted as candidate mediators: average sleep duration and mid-sleep on free days corrected for sleep debt, abbreviated MSFsc, a widely used proxy for chronotype developed by chronobiologist Till Roenneberg and colleagues. Chronotype captures whether a person’s internal circadian clock leans toward morningness or eveningness, a trait that shifts markedly later during adolescence as puberty advances.

The outcomes were analyzed with separate statistical models. Grade point average, treated as a continuous measure, was modeled using linear regression, while school absences, which are count data, were modeled using Poisson regression, an approach suited to non-negative integer outcomes. All models adjusted for sociodemographic covariates. This dual-model design allowed the team to estimate, separately for GPA and absences, whether the sleep measures carried any of the association between race or ethnicity and academic outcomes.

The total effects were substantial and statistically significant. Compared with White students, Black students had lower GPAs, with a regression coefficient of negative 2.70 and a 95 percent confidence interval spanning negative 5.06 to negative 0.42. Asian students, by contrast, had higher GPAs than their White peers, with a coefficient of 5.46 and a confidence interval of 2.44 to 8.10. Attendance patterns diverged as well. Asian students were less likely to be absent than White students, with a relative risk of 0.51, and Hispanic students also showed lower absence rates, with a relative risk of 0.59. In other words, Asian students in this sample were roughly half as likely to miss school as White students, and Hispanic students about 40 percent less likely.

Yet when the researchers tested whether sleep duration or MSFsc mediated these differences, the mediation effects were not statistically significant for either GPA or absences. The sleep measures did not carry the association between race or ethnicity and academic outcomes. This null mediation result is the study’s central finding, and it carries real weight precisely because the underlying disparities were clearly present in the data. The authors conclude that factors beyond these two sleep dimensions likely contribute to the observed academic inequities.

The result complicates a popular narrative. Sleep is undeniably important for adolescents: the National Sleep Foundation recommends eight to ten hours per night for teenagers, and meta-analytic reviews have consistently linked shorter sleep duration, poorer sleep quality, and greater sleepiness to weaker school performance. Later school start times have been shown in actigraphic studies to lengthen adolescent sleep, and delayed circadian phase in puberty is well established. Given documented racial and ethnic sleep disparities among United States children and adolescents, and evidence that discrimination is associated with disrupted sleep, the idea that sleep might partially explain achievement gaps was plausible and, importantly, testable. Interventions targeting sleep, such as adjusted start times or sleep hygiene education, would be comparatively tractable compared with the deeper structural forces shaping educational outcomes.

But this study suggests that such interventions, at least as measured here, would not close the GPA or attendance gaps on their own. Several technical considerations temper the interpretation. The design was cross-sectional, capturing a single snapshot rather than tracking students over time, so causal claims about mediation are inherently limited. The sleep measures were not objective; actigraphy or polysomnography might reveal differences that self-reported or estimated duration and chronotype proxies miss. The authors themselves call for longitudinal studies using objective sleep assessments. Additionally, the sample comprised 406 students from two schools in semi-rural Georgia, a setting that may not generalize to urban districts or other regions, and the mediation framework tested only two candidate mediators out of a vast space of possible pathways.

The broader implications point researchers toward other explanatory candidates. Chronic absenteeism has been linked to school climate, disciplinary practices, socioeconomic conditions, health access, and family circumstances, and prior work on racial disparities in discipline suggests that school-level factors, not just individual behavior, shape attendance and achievement. Sleep quality, sleep disorders, environmental disruptions such as noise and light exposure, and stress from discrimination may all matter in ways that simple duration and chronotype measures do not capture. The study, funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Heart, Lung, and Blood Institute, does not diminish the case for healthy adolescent sleep; it simply shows that the arithmetic of educational inequity cannot be reduced to hours slept or a preference for evenings.

For educators and policymakers, the message is twofold. Sleep remains a legitimate target for improving adolescent health and functioning across all groups, and later start times still offer documented benefits for sleep duration. But closing racial and ethnic gaps in grades and attendance will require attention to the social and structural determinants that this study’s null mediation result implicitly highlights. The Georgia ninth graders in this dataset arrived at school with differences in performance and presence that their sleep clocks, however measured, could not account for, and that finding should redirect both scientific inquiry and intervention design toward the fuller set of forces shaping who thrives in American high schools.

Subject of Research: Racial and ethnic disparities in academic performance and absenteeism among adolescents and the role of sleep duration and chronotype

Article Title: Racial/ethnic disparities in grade point averages and absences among 9th graders in Georgia: the role of sleep differences

Article References: Teferi, H. M., Mathew, G. M., Hale, L., Johnson, D. A., & Gazmararian, J. A. (2026). Racial/ethnic disparities in grade point averages and absences among 9th graders in Georgia: the role of sleep differences. Journal of Clinical Sleep Medicine, 22(1), Article 182. https://doi.org/10.1007/s44470-026-00187-4

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00187-4

Keywords: sleep duration, chronotype, grade point average, school absences, racial disparities, adolescents, mediation analysis, Georgia, sleep health, academic achievement, ninth grade, circadian rhythms

The team deployed an unusually broad technical arsenal to interrogate the question. They combined electrical stimulation of the SCN region in brain slices with visual stimulation of light-exposed animals, perforated multielectrode array recordings that capture the firing of many neurons simultaneously over hours, c-Fos mapping to visualise which cells were activated in the living brain, and detailed neuroanatomical tracing of retinal projections. This multi-pronged strategy matters because no single method could disentangle the two influences at play: the time-of-day signal emanating from the SCN and the moment-to-moment photic signal arriving from the eye.

The first surprise was the sheer diversity of responses. Across the midline hypothalamus—encompassing regions such as the paraventricular nucleus, the dorsomedial and anterior dorsomedial hypothalamus, the anterior hypothalamic area, the anterior ventromedial hypothalamus, the arcuate nucleus, the medial preoptic area, the lateral hypothalamic area and the retrochiasmatic area—the researchers found distinct cell populations that fell into different functional classes. Some received inhibitory input of SCN origin, some excitatory input, and some both. When the SCN region was stimulated electrically in slices, hypothalamic neurons responded with a mixture of fast excitatory postsynaptic currents and inhibitory currents, revealing that the master clock does not simply broadcast a uniform suppressive message to its hypothalamic targets.

Crucially, the responses were not confined to SCN-derived signals. The recordings revealed excitatory and inhibitory responses of retinal origin in hypothalamic cells, indicating that photic information arrives through routes that bypass, or at least run in parallel to, the classical SCN relay. The pharmacology supported this: blocking ionotropic glutamate receptors abolished the fast excitatory components, while the GABA receptor antagonist bicuculline unmasked inhibitory drive, consistent with glutamate and GABA acting as the principal transmitters carrying both circadian and retinal messages into these downstream nuclei.

Ex vivo recordings of hypothalamic slices maintained in artificial cerebrospinal fluid added a temporal dimension. Even when isolated from the body, different hypothalamic cell populations displayed divergent circadian activity patterns—some firing vigorously at what would be daytime in the donor animal, others peaking at night, and others showing phase relationships that shifted depending on where in the hypothalamus the cells resided. This differential phase resetting means the hypothalamus is not a passive uniform follower of the SCN clock; it hosts multiple local oscillators with distinct timing signatures, each potentially tuned to different physiological outputs such as hormone secretion, thermoregulation, feeding or sleep-wake control.

Back in the living animal, the picture sharpened further. Light-evoked activity in the hypothalamus in vivo was dominated by melanopsin—the photopigment found in intrinsically photosensitive retinal ganglion cells, the specialised neurons that also drive circadian photoentrainment and the pupil reflex. The melanopsin-dominated character of the hypothalamic visual responses aligned neatly with the distribution of direct retinal projections traced by the anatomical experiments: the regions that received the densest retinal innervation were the ones showing the strongest light-driven activation. Neutral density filters that attenuated light intensity, and comparisons across Zeitgeber times, allowed the team to separate the photic component from the circadian component of hypothalamic firing.

The c-Fos mapping experiments then delivered the study’s most visually compelling result. When the researchers quantified c-Fos expression—the classic molecular fingerprint of recent neuronal activation—across hypothalamic subregions, they found a striking mosaic. Some discrete subregions were dominated by circadian signals, lighting up according to time of day regardless of illumination. Others were dominated by light, responding to illumination irrespective of clock phase. And a third set responded to both, integrating the internal clock with the external light environment. This anatomical segregation of circadian, photic and combined influences means the hypothalamus is organised into parallel channels rather than a single SCN-gated pipeline.

The implications ripple outward well beyond rodent neuroanatomy. The hypothalamic nuclei implicated in this study are major effector sites for physiology: the paraventricular nucleus orchestrates the hormonal stress axis and autonomic output, the dorsomedial hypothalamus helps coordinate sleep-wake and feeding rhythms, the arcuate nucleus governs appetite and energy balance, and the ventromedial hypothalamus is central to defensive behaviour and metabolic regulation. If light can modulate these circuits directly, through melanopsin-driven retinal input, then environmental illumination has a far more immediate and granular influence on physiology than the SCN-suppression model allowed. It also offers new substrates for understanding how light can be adaptive—sharpening daily rhythms—and how it can be disruptive, as in the metabolic and mood disturbances associated with irregular light exposure, shift work and excessive evening screen use.

The study also reframes how we think about the SCN itself. Rather than a despotic conductor whose output wholly determines hypothalamic state, the master clock emerges as one player in a distributed network, contributing inhibitory and excitatory signals that interact with independent retinal channels. The finding that SCN-derived responses include both inhibitory and excitatory components challenges the textbook framing of daytime SCN output as uniformly suppressive on downstream hypothalamic effectors. Instead, the SCN appears to shape hypothalamic activity with the same kind of push-pull synaptic logic found elsewhere in the brain, while the retina delivers a second, parallel stream of information that can act on the same nuclei on its own timescale.

Methodologically, the work sets a benchmark for how to disentangle circadian and photic influences on neural activity. By pairing long-duration ex vivo multielectrode recordings—capable of tracking slice activity across the circadian cycle—with in vivo visual stimulation, pharmacological dissection of glutamatergic and GABAergic transmission, and quantitative c-Fos mapping validated against anatomical templates, the Manchester team built a converging chain of evidence in which each line of attack compensates for the limitations of the others. The result is a coherent map of where, when and how light and time-of-day signals converge in the hypothalamus. What remains to be explored is how these parallel channels influence specific physiological outputs—whether direct retinal drive to the paraventricular nucleus, for instance, acutely modulates stress hormones, or whether melanopsin input to feeding circuits contributes to the appetite-suppressing effects of bright light. The authors’ data establish that light-dependent activity across the anterior midline hypothalamus is surprisingly extensive, and in doing so they open a rich new seam for research into how the light environment shapes, and sometimes scrambles, the daily biology of mammals—including, very likely, ourselves.

Subject of Research: Parallel retinal and circadian signalling pathways regulating light-dependent activity in the mouse hypothalamus

Article Title: Parallel retinal and circadian signalling channels organise mouse hypothalamic activity

Article References: Gurung, B., Harding, C., Mouland, J. W., Sahid, N., Ray, H., Bechtold, D. A., & Brown, T. M. (2026). Parallel retinal and circadian signalling channels organise mouse hypothalamic activity. BMC Biology. https://doi.org/10.1186/s12915-026-02746-w

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02746-w

Keywords: suprachiasmatic nucleus, hypothalamus, circadian rhythms, melanopsin, intrinsically photosensitive retinal ganglion cells, retinohypothalamic tract, c-Fos mapping, multielectrode recordings, paraventricular nucleus, dorsomedial hypothalamus, light exposure, electrophysiology